Transfusion-associated circulatory overload (TACO)
- Arthur J Silvergleid, MD
Arthur J Silvergleid, MD
- Section Editor — Transfusion Medicine
- Affiliate Associate Professor, Department of Pathology and Cell Biology
- University of South Florida, College of Medicine
- Medical Director, OneBlood, Inc.
Reactions to blood component transfusion can range from mild to potentially fatal. Transfusion-associated circulatory overload (TACO) is a common transfusion reaction in which pulmonary edema develops primarily due to volume excess or circulatory overload. TACO typically occurs in patients who receive a large volume of a transfused product over a short period of time, or in those with underlying cardiovascular or renal disease.
This topic reviews the clinical manifestations, diagnosis, management, and prevention of TACO.
A general approach to a suspected transfusion reaction, as well as other specific reactions, are presented in detail separately:
●General approach – (See "Approach to the patient with a suspected acute transfusion reaction".)
●Transfusion-related acute lung injury (TRALI) – (See "Transfusion-related acute lung injury (TRALI)".)
Subscribers log in hereLiterature review current through: Jul 2017. | This topic last updated: Jan 11, 2017.References
- Alam A, Lin Y, Lima A, et al. The prevention of transfusion-associated circulatory overload. Transfus Med Rev 2013; 27:105.
- Lieberman L, Maskens C, Cserti-Gazdewich C, et al. A retrospective review of patient factors, transfusion practices, and outcomes in patients with transfusion-associated circulatory overload. Transfus Med Rev 2013; 27:206.
- Menis M, Anderson SA, Forshee RA, et al. Transfusion-associated circulatory overload (TACO) and potential risk factors among the inpatient US elderly as recorded in Medicare administrative databases during 2011. Vox Sang 2014; 106:144.
- Murphy EL, Kwaan N, Looney MR, et al. Risk factors and outcomes in transfusion-associated circulatory overload. Am J Med 2013; 126:357.e29.
- Hendrickson JE, Roubinian NH, Chowdhury D, et al. Incidence of transfusion reactions: a multicenter study utilizing systematic active surveillance and expert adjudication. Transfusion 2016; 56:2587.
- Popovsky MA, Audet AM, Andrzejewski C Jr. Transfusion-associated circulatory overload in orthopedic surgery patients: a multi-institutional study. Immunohematology 1996; 12:87.
- Bierbaum BE, Callaghan JJ, Galante JO, et al. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999; 81:2.
- Clifford L, Jia Q, Yadav H, et al. Characterizing the epidemiology of perioperative transfusion-associated circulatory overload. Anesthesiology 2015; 122:21.
- Bolton-Maggs PH. Bullet points from SHOT: key messages and recommendations from the Annual SHOT Report 2013. Transfus Med 2014; 24:197.
- Narick C, Triulzi DJ, Yazer MH. Transfusion-associated circulatory overload after plasma transfusion. Transfusion 2012; 52:160.
- Piccin A, Cronin M, Brady R, et al. Transfusion-associated circulatory overload in Ireland: a review of cases reported to the National Haemovigilance Office 2000 to 2010. Transfusion 2015; 55:1223.
- Bernasinski M, Mertes PM, Carlier M, et al. [Respiratory complications after transfusion]. Transfus Clin Biol 2014; 21:60.
- Raval JS, Mazepa MA, Russell SL, et al. Passive reporting greatly underestimates the rate of transfusion-associated circulatory overload after platelet transfusion. Vox Sang 2015; 108:387.
- http://www.bcshguidelines.com/documents/ATR_final_version_to_pdf.pdf (Accessed on July 27, 2016).
- Zhou L, Giacherio D, Cooling L, Davenport RD. Use of B-natriuretic peptide as a diagnostic marker in the differential diagnosis of transfusion-associated circulatory overload. Transfusion 2005; 45:1056.
- Li G, Daniels CE, Kojicic M, et al. The accuracy of natriuretic peptides (brain natriuretic peptide and N-terminal pro-brain natriuretic) in the differentiation between transfusion-related acute lung injury and transfusion-related circulatory overload in the critically ill. Transfusion 2009; 49:13.
- Tobian AA, Sokoll LJ, Tisch DJ, et al. N-terminal pro-brain natriuretic peptide is a useful diagnostic marker for transfusion-associated circulatory overload. Transfusion 2008; 48:1143.
- Tseng E, Spradbrow J, Cao X, et al. An order set and checklist improve physician transfusion ordering practices to mitigate the risk of transfusion-associated circulatory overload. Transfus Med 2016; 26:104.
- Maynard K. Administration of Blood Components. In: Technical Manual, 18th edition, Fung MK, Grossman BJ, Hillyer CD, et al. (Eds), AABB, 2014.
- PATHOPHYSIOLOGY AND RISK FACTORS
- CLINICAL PRESENTATION
- DIAGNOSTIC TESTING
- Evaluation and diagnosis
- DIFFERENTIAL DIAGNOSIS
- Transfusion reactions/TRALI
- Other causes of heart failure
- Pulmonary embolism
- Overview of prevention
- Transfusion rates
- Reducing RBC volume
- SUMMARY AND RECOMMENDATIONS